Back to User profile » Dr Kangxian Zhao

Papers published by Dr Kangxian Zhao:

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway

Wu X, Zhao K, Fang X, Lu F, Zhang W, Song X, Chen L, Sun J, Chen H

Drug Design, Development and Therapy 2021, 15:4741-4757

Published Date: 23 November 2021

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo

Sun P, Yang Q, Wang Y, Peng J, Zhao K, Jia Y, Zhang T, Lu X, Han W, Qian Y

Drug Design, Development and Therapy 2020, 14:4189-4203

Published Date: 9 October 2020

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo

Peng J, Zhao K, Zhu J, Wang Y, Sun P, Yang Q, Zhang T, Han W, Hu W, Yang W, Ruan J, Qian Y

Drug Design, Development and Therapy 2020, 14:3435-3447

Published Date: 24 August 2020